Gartner Research

Hype Cycle for Life Science Commercial Operations, 2020

Published: 06 August 2020

ID: G00450345

Analyst(s): Animesh Gandhi , Michael Shanler


This Hype Cycle helps life science CIOs identify and prioritize the most strategic and relevant technology investments to transform the commercialization of therapeutic products. CIOs should use this research to understand the business value, maturity levels and adoption rates.

Table Of Contents


  • What You Need to Know
  • The Hype Cycle
  • The Priority Matrix
  • Off the Hype Cycle
  • On the Rise
    • Immersive Technologies for Care Delivery
    • Precision Health
    • Digital Life Science Platform (DLSP)
    • Life Science Patient Engagement Hub
    • Prescribed Digital Therapeutics
    • Cell and Gene Therapy Platform
    • Advanced Decision Support for Sales
    • Health Data Curation and Enrichment
    • Immersive AR/VR/MR Experiences in Life Science
    • Conversational Chatbots for Analytics
  • At the Peak
    • Life Science Sales Performance Management
    • Life Science Multichannel Campaign Management
    • AI in Commercial Operations
    • Consent and Preference Management
    • Blockchain in Life Sciences
    • Consumer Healthcare Wearables
    • Life Science Account Management and Selling
    • Voice-Driven Sales Apps
  • Sliding Into the Trough
    • Genomics Medicine
    • Social Media Analytics
    • Key Opinion Leader Management
    • Physician Social Media
    • Medication Compliance Management
    • Sales Training and Coaching Solutions
    • Direct-to-Patient Digital Marketing
    • Data Lakes
  • Climbing the Slope
    • Remote Patient Monitoring
    • Cloud Computing
    • MDM of Customer Data
    • Predictive Analytics
    • Revenue Management
  • Entering the Plateau
    • Aggregate-Spending Tracking and Transparency Reporting
    • Web-Based E-Detailing
  • Appendixes
    • Hype Cycle Phases, Benefit Ratings and Maturity Levels

Gartner Recommended Reading

©2020 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.